Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition: Tuberculosis, Pulmonary Intervention: Drug: 4-month rifapentine-based regimen Sponsors: Kaohsiung Veterans General Hospital.; National Taiwan University; Taipei Veterans General Hospital, Taiwan; Chang Gung Memorial Hospital; Centers for Disease Control, Taiwan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials